WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 56.05
+2.55 (4.77%)
Sep 30, 2026, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 230.01 billion as of October 1, 2026. Its market cap has increased by 42.93% in one year.
Market Cap
230.01B
Enterprise Value
225.57B
Revenue
27.27B
Ranking
n/a
PE Ratio
40.99
Stock Price
56.05
ChartMarket Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 230.01B, an increase of 617.92%. That is a compound annual growth rate of 23.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 230.01B | 76.99% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 327.35B |
| Innovent Biologics | 166.95B |
| Sichuan Kelun-Biotech Biopharmaceutical | 108.80B |
| Sino Biopharmaceutical | 98.85B |
| Akeso | 97.92B |
| Genscript Biotech | 94.41B |
| RemeGen | 62.48B |
| Biocytogen Pharmaceuticals (Beijing) | 57.42B |